000			03967cam a22004457i 4500
999			_c3795 _d3795
001			17898020
003			OSt
005			20200228114155.0
008			130925t20132013ne a b 001 0 eng d
010			_a 2013370264
015			_aGBB279252 _2bnb
016	7		_a016147232 _2Uk
020			_a9780123919243 (hdbk.)
020			_a012391924X (hdbk.)
035			_a(OCoLC)ocn802326809
040			_aBTCTA _beng _cBTCTA _erda _dUKMGB _dYDXCP _dCDX _dBDX _dLML _dKSU _dEAU _dMYG _dU3G _dDXU _dOCLCQ _dNLGGC _dDLC
042			_alccopycat
050	0	0	_aRC553.A88 _bN536 2013
082	0	4	_a616.858 82 BOX H; 1 _223
084			_a44.91 _2bcl
084			_a77.50 _2bcl
245	0	4	_aThe neuroscience of autism spectrum disorders / _c[edited by] Joseph D. Buxbaum, Patrick R. Hof,
250			_aFirst edition.
264		1	_aAmsterdan ; _aBoston : _bElsevier/AP, _c2013.
264		4	_c©2013
300			_axii, 480 pages : _billustrations (chiefly color) ; _c28 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505			_aSection 1: Autism Spectrum Disorders 1.1 Epidemiology of autism spectrum disorders; 1.2 The behavioral manifestations of autism spectrum disorders; 1.3 Early manifestations of autism spectrum disorders; 1.4 Asperger Syndrome and Its Relationship to Autism Spectrum Disorders; 1.5 Behavioral and Psychosocial Interventions for Individuals with ASD; 1.6 Current Trends in the Pharmacological Treatment of Autism Spectrum Disorders; 1.7 Novel therapeutics in autism spectrum disorders Section 2: Etiology of Autism Spectrum Disorders 2.1 Medical genetics and autism spectrum disorders; 2.2 Copy Number Variation in Autism Spectrum Disorders; 2.3 Common genetic variants in autism spectrum disorders; 2.4 Next-Generation Sequencing for Gene and Pathway Discovery and Analysis in Autism Spectrum Disorders; 2.5 Mitochondria and Autism Spectrum Disorders; 2.6 Parental and perinatal risk factors in ASDs; 2.7 The Environment in autism spectrum disorders; 2.8 Hormonal influences in typical development: Implications for autism; 2.9 Immune abnormalities and autism spectrum disorders Section 3: Brain Imaging and Neuropatholgy of Autism Spectrum Disorders 3.1 Structural and functional MRI studies of autism spectrum disorders; 3.2 DTI and tractography in the autistic brain; 3.3 Attentional network deficits in autism spectrum disorders; 3.4 The cerebellum in autism spectrum disorders; 3.5 The amygdala in autism spectrum disorders; 3.6 Discrete cortical neuropathology in autism spectrum disorders; 3.7 The minicolumnopathy of autism spectrum disorders; 3.8 Inhibitory and excitatory systems in autism spectrum disorders; 3.9 Clinicopathological Stratification of Idiopathic Autism and Autism Associated with 15q11.2-q13 Duplications Section 4: Model Systems and Pathways in Autism Spectrum Disorders 4.1 Mouse behavioral models for autism spectrum disorders; 4.2 Nonhuman primate models for autism spectrum disorders; 4.3 Inducible pluripotent stem cells in ASDs; 4.4 A 15q11-q13 duplication mouse model for autism spectrum disorders; 4.5 Fragile X syndrome and autism spectrum disorders; 4.6 MECP2 and autism spectrum disorders; 4.7 SHANK2 and SHANK3 Mutations Implicate Glutamate Signaling Abnormalities in Autism Spectrum Disorders; 4.8 PI3K signaling and miRNA regulation in autism spectrum disorders; 4.9 Getting from 1000 genes to a triad of symptoms: The emerging role of systems biology in autism spectrum disorders
650		0	_aAutism spectrum disorders.
650		0	_aNeurosciences.
650		2	_aChild Developmental Disorders, Pervasive.
700	1		_aBuxbaum, Joseph D., _eeditor.
700	1		_aHof, Patrick R., _eeditor.
906			_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cSTS